alendronic acid
ItalyDrugs containing this active substance
-
The drug is used to treat osteoporosis in men and women after menopause, reducing the risk of vertebral and hip fractures. It is also used to treat and prevent osteoporosis caused by the use of a particular class of anti-inflammatory medicines, glucocorticoids.
Form: tablets
Active substance Dosage alendronic acid - ATC: M05BA04
Manufacturer: NEOPHARMED GENTILI S.P.A.
-
It is prescribed for the treatment of osteoporosis in postmenopausal women. It is used to prevent bone tissue loss, promote bone reconstruction, and reduce the risk of spinal and hip fractures.
Form: tablets, film-coated
Active substance Dosage alendronic acid - ATC: M05BA04
Manufacturer: LABORATORI ALTER S.R.L.
-
It is prescribed for the treatment of osteoporosis in postmenopausal women. It is used to prevent the loss of bone tissue, promote bone rebuilding, and reduce the risk of spinal and hip fractures.
Form: tablets
Active substance Dosage alendronic acid - ATC: M05BA04
Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.
-
It is prescribed for the treatment of osteoporosis in postmenopausal women. It is used to prevent the loss of bone tissue, promote bone reconstruction, and reduce the risk of spinal and hip fractures.
Form: tablets
Active substance Dosage alendronic acid - ATC: M05BA04
Manufacturer: FG S.R.L.
-
This medicine is prescribed for the treatment of osteoporosis and to reduce the risk of vitamin D deficiency. In postmenopausal women, it helps to reduce the risk of spinal and hip fractures.
Form: tablets
Active substance Dosage alendronic acid - cholecalciferol - ATC: M05BB03
Manufacturer: TEVA ITALIA S.R.L.
-
Binosto is prescribed for the treatment of osteoporosis. It is used to prevent the loss of bone tissue in women after menopause, promotes bone rebuilding, and reduces the risk of spinal and hip fractures.
Form: tablets, effervescent
Active substance Dosage alendronic acid - ATC: M05BA04
Manufacturer: ABIOGEN PHARMA S.P.A.
-
It is used to prevent bone loss (osteoporosis) in post-menopausal women, helps to rebuild bone tissue, and reduces the risk of spinal and hip fractures.
Form: solution, oral
Active substance Dosage alendronic acid - ATC: M05BA04
Manufacturer: BRUNO FARMACEUTICI S.P.A.
-
FOSAMAX is prescribed for the treatment of osteoporosis. It is used to prevent the loss of bone tissue in women after menopause, promote bone rebuilding, and reduce the risk of spinal and hip fractures.
Form: tablets
Active substance Dosage alendronic acid - ATC: M05BA04
Manufacturer: ORGANON ITALIA S.R.L.
-
It is prescribed for the treatment of osteoporosis in postmenopausal women. It is used to prevent bone tissue loss, promote bone reconstruction, and reduce the risk of hip and spinal fractures.
Form: tablets
Active substance Dosage alendronic acid - ATC: M05BA04
Manufacturer: NEOPHARMED GENTILI S.P.A.